Catalyst
Slingshot members are tracking this event:
First Patient Enrolled in Mallinckrodt (MNK) Phase 4 Trial of H.P. Acthar Gel for Rheumatoid Arthritis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MNK |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 14, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Acthar Gel, Rheumatoid Arthritis
